Aarkstore - Essential Thrombocythemia - Pipeline Review, H2 2014 - PowerPoint PPT Presentation

About This Presentation
Title:

Aarkstore - Essential Thrombocythemia - Pipeline Review, H2 2014

Description:

“Essential Thrombocythemia - Pipeline Review, H2 2014”, provides an overview of the Essential Thrombocythemias therapeutic pipeline. For more details : – PowerPoint PPT presentation

Number of Views:32

less

Transcript and Presenter's Notes

Title: Aarkstore - Essential Thrombocythemia - Pipeline Review, H2 2014


1
Aarkstore - Essential Thrombocythemia - Pipeline
Review, H2 2014
www.aarkstore.com
2
Summary
  • Essential Thrombocythemia - Pipeline Review, H2
    2014, provides an overview of
  • the Essential Thrombocythemias therapeutic
    pipeline.
  • This Market Research Report provides
    comprehensive information on the therapeutic
  • development for Essential Thrombocythemia,
    complete with comparative analysis at various
  • stages, therapeutics assessment by drug target,
    mechanism of action (MoA), route of
  • administration (RoA) and molecule type, along
    with latest updates, and featured news and
  • press releases. It also reviews key players
    involved in the therapeutic development for
  • Essential Thrombocythemia and special features on
    late-stage and discontinued projects.

www.aarkstore.com
www.aarkstore.com
3
Scope
  • - The report provides a snapshot of the
    global therapeutic landscape of Essential
    Thrombocythemia- The report reviews key pipeline
    products under drug profile section which
    includes, product description, MoA and RD brief,
    licensing and collaboration details other
    developmental activities - The report reviews
    key players involved in the therapeutics
    development for Essential Thrombocythemia and
    enlists all their major and minor projects- The
    report summarizes all the dormant and
    discontinued pipeline projects - A review of the
    Essential Thrombocythemia products under
    development by companies and universities/research
    institutes based on information derived from
    company and industry-specific sources- Pipeline
    products coverage based on various stages of
    development ranging from pre-registration till
    discovery and undisclosed stages- A detailed
    assessment of monotherapy and combination therapy
    pipeline projects- Coverage of the Essential
    Thrombocythemia pipeline on the basis of target,
    MoA, route of administration and molecule type-
    Latest news and deals relating related to
    pipeline products

www.aarkstore.com
www.aarkstore.com
4
Reasons to buy
  • - Provides strategically significant
    competitor information, analysis, and insights to
    formulate effective RD development strategies-
    Identify emerging players with potentially strong
    product portfolio and create effective
    counter-strategies to gain competitive
    advantage- Develop strategic initiatives by
    understanding the focus areas of leading
    companies- Identify and understand important and
    diverse types of therapeutics under development
    for Essential Thrombocythemia- Plan mergers and
    acquisitions effectively by identifying key
    players of the most promising pipeline- Devise
    corrective measures for pipeline projects by
    understanding Essential Thrombocythemia pipeline
    depth and focus of Indication therapeutics-
    Develop and design in-licensing and out-licensing
    strategies by identifying prospective partners
    with the most attractive projects to enhance and
    expand business potential and scope- Modify the
    therapeutic portfolio by identifying discontinued
    projects and understanding the factors that drove
    them from pipeline

www.aarkstore.com
www.aarkstore.com
5
Table of Contents
  • Introduction Global Markets Direct Report
    Coverage Essential Thrombocythemia Overview
    Therapeutics Development Pipeline Products for
    Essential Thrombocythemia - Overview Pipeline
    Products for Essential Thrombocythemia -
    Comparative Analysis Essential Thrombocythemia -
    Therapeutics under Development by Companies
    Essential Thrombocythemia - Therapeutics under
    Investigation by Universities/Institutes
    Essential Thrombocythemia - Pipeline Products
    Glance Late Stage Products Clinical Stage
    Products Early Stage Products Essential
    Thrombocythemia - Products under Development by
    Companies Essential Thrombocythemia - Products
    under Investigation by Universities/Institutes
    Essential Thrombocythemia - Companies Involved
    in Therapeutics Development AstraZeneca PLC

www.aarkstore.com
www.aarkstore.com
6
List Of Tables
  • Number of Products under Development for
    Essential Thrombocythemia, H2 2014 Number of
    Products under Development for Essential
    Thrombocythemia - Comparative Analysis, H2 2014
    Number of Products under Development by
    Companies, H2 2014 Number of Products under
    Investigation by Universities/Institutes, H2 2014
    1Comparative Analysis by Late Stage Development,
    H2 2014 Comparative Analysis by Clinical Stage
    Development, H2 2014 Comparative Analysis by
    Early Stage Development, H2 2014 Products under
    Development by Companies, H2 2014 Products under
    Investigation by Universities/Institutes, H2 2014
    Essential Thrombocythemia - Pipeline by
    AstraZeneca PLC, H2 2014

www.aarkstore.com
7
List Of Figures
  • Number of Products under Development for
    Essential Thrombocythemia, H2 2014 Number of
    Products under Development for Essential
    Thrombocythemia - Comparative Analysis, H2 2014
    Number of Products under Development by
    Companies, H2 2014 Comparative Analysis by
    Clinical Stage Development, H2 2014 Assessment
    by Monotherapy Products, H2 2014 Number of
    Products by Top 10 Target, H2 2014 Number of
    Products by Stage and Top 10 Target, H2 2014
    Number of Products by Top 10 Mechanism of
    Action, H2 2014 Number of Products by Stage and
    Top 10 Mechanism of Action, H2 2014 Number of
    Products by Top 10 Route of Administration, H2
    2014

www.aarkstore.com
8
Related Market Research reports
  • Blirt S.A. - Product Pipeline Review 2014
  • Auris Medical Holding AG - Product Pipeline
    Review 2014
  • Integral Molecular, Inc. - Product Pipeline
    Review 2014
  • DaVinci Biosciences, LLC - Product Pipeline
    Review 2014
  • Actavis plc - Product Pipeline Review - 2014

www.aarkstore.com
9
Related Market Research reports
  • TiGenix NV - Product Pipeline Review 2014
  • Egenix, Inc. - Product Pipeline Review 2014
  • SkyePharma PLC - Product Pipeline Review 2014
  • MediWound Ltd. - Product Pipeline Review 2014
  • BioTech Tools s.a. - Product Pipeline Review -
    2014

www.aarkstore.com
10
Aarkstore - Essential Thrombocythemia - Pipeline
Review, H2 2014
Format Price
PDF 2000
Site Licence 4000
Enterprise Wide Licence  6000
www.aarkstore.com
11
Contact Us
  • Office
  • Office No. - 809, 8th Floor,
  • B-Wing, Mahaavir Icon, 
  • Plot No.- 89 90, Sector-15,
  • CBD-Belapur, Navi Mumbai 400614, 
  • Maharashtra, India.
  • 24/7 Online Support 91 9987295242
  • General Inquiries 91 - 22 2756 4953
  • You Can Visit http//www.aarkstore.com
  • OR Mail us at contact_at_aarkstore.com
  • Blog http//www.aarkstore.com/blog/
  • Conference http//conference.aarkstore.com/
  • News http//www.aarkstore.com/news

www.aarkstore.com
Write a Comment
User Comments (0)
About PowerShow.com